US Stock MarketDetailed Quotes

MYGN Myriad Genetics

Watchlist

8.880
-0.340-3.69%

Close Mar 28 16:00 ET

9.050
+0.170+1.91%

Post 20:01 ET

810.82MMarket Cap-6.30P/E (TTM)

Myriad Genetics Key Stats

Myriad Genetics Q4 2024 Earnings Date

Currency：USDFeb 24, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	210.35M	210.60M	+251.41K
Beat Est.	+6.99%	+7.12%	+0.12%
EPS	-0.40	-0.47	-0.07
Miss Est.	-10.56%	-30.56%	-18.12%

Analyst Rating

Hold

Mar 29, 2025

Myriad Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 212.766M	--
--	2025/Q1	-- / 201.155M	--
Feb 24, 2025	2024/Q4	210.600M / 210.349M	--
Nov 7, 2024	2024/Q3	213.300M / 210.794M	--
Aug 6, 2024	2024/Q2	211.500M / 205.006M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 212.766M--

--2025/Q1-- / 201.155M--

Feb 24, 20252024/Q4210.600M / 210.349M--

Nov 7, 20242024/Q3213.300M / 210.794M--

Aug 6, 20242024/Q2211.500M / 205.006M--

Unlock Free Earnings Estimates

Open Account

Myriad Genetics Earnings Reports

Myriad Genetics | 10-K: FY2024 Annual Report

Feb 28 16:06 ET

Myriad Genetics | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 08:19 ET

Myriad Genetics | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 08:26 ET

Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Aug 6, 2024 16:18 ET

Market Insights

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Collegium Pharmaceutical

COLL

+0.51%